Source: BMC health services research [BMC Health Serv Res] 2024 Oct 01; Vol. 24 (1), pp. 1158. Date of Electronic Publication: 2024 Oct 01.Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Do beta-amyloid-targeted interventions improve cognition, physical functioning, and overt behaviour of Alzheimer's Disease (AD) patients: Protocol for meta-analysis of Phase 3 clinical trials both completed and terminated.

Authors : Stellick Bedrejo CA; Department of Psychiatry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.; Greenshaw A

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/metabolism ; Amyloid beta-Peptides*/Amyloid beta-Peptides*/Amyloid beta-Peptides*/antagonists & inhibitors

Source: PloS one [PLoS One] 2024 Sep 27; Vol. 19 (9), pp. e0307761. Date of Electronic Publication: 2024 Sep 27 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Rapid normalization of vitamin D deficiency in PICU (VITdALIZE-KIDS): study protocol for a phase III, multicenter randomized controlled trial.

Authors : O'Hearn K; Menon K ...

Subjects: Critical Illness* ; Vitamin D Deficiency*/Vitamin D Deficiency*/Vitamin D Deficiency*/drug therapy ; Vitamin D Deficiency*/Vitamin D Deficiency*/Vitamin D Deficiency*/blood

Source: Trials [Trials] 2024 Sep 19; Vol. 25 (1), pp. 619. Date of Electronic Publication: 2024 Sep 19.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Drug-resistant tuberculosis treatments, the case for a phase III platform trial.

Authors : Yates TA; Barnes S ...

Subjects: Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/drug therapy ; Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/therapeutic use ; Clinical Trials, Phase III as Topic*

Source: Bulletin of the World Health Organization [Bull World Health Organ] 2024 Sep 01; Vol. 102 (9), pp. 657-664.Publisher: World Health Organization Country of Publication: Switzerland NLM ID: 7507052 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial.

Authors : McKetin R; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia. .; Degan TJ

Subjects: Mirtazapine*/Mirtazapine*/Mirtazapine*/therapeutic use ; Amphetamine-Related Disorders*/Amphetamine-Related Disorders*/Amphetamine-Related Disorders*/drug therapy ; Amphetamine-Related Disorders*/Amphetamine-Related Disorders*/Amphetamine-Related Disorders*/psychology

Source: Trials [Trials] 2024 Jun 22; Vol. 25 (1), pp. 408. Date of Electronic Publication: 2024 Jun 22.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Adult and pediatric relapsing multiple sclerosis phase II and phase III trial design and their primary end points: A systematic review.

Authors : Hiramatsu K; Department of Regulatory Science, Faculty of Pharmacy, Meiji Pharmaceutical University, Tokyo, Japan.; Maeda H

Subjects: Clinical Trials, Phase III as Topic* ; Clinical Trials, Phase II as Topic* ; Multiple Sclerosis, Relapsing-Remitting*/Multiple Sclerosis, Relapsing-Remitting*/Multiple Sclerosis, Relapsing-Remitting*/drug therapy

Source: Clinical and translational science [Clin Transl Sci] 2024 May; Vol. 17 (5), pp. e13794.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis.

Authors : Wu X; Medical School of Nanjing University, Nanjing, 210000, China.; Xu K

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage

Source: BMC infectious diseases [BMC Infect Dis] 2024 Feb 21; Vol. 24 (1), pp. 234. Date of Electronic Publication: 2024 Feb 21.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Correlation of multiple endpoints in the first-line chemotherapy of advanced gastric cancer: Pooled analysis of individual patient data from Japanese Phase III trials.

Authors : Arai H; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Japan.; Takeuchi M

Subjects: Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/drug therapy ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/mortality ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/pathology

Source: Cancer medicine [Cancer Med] 2024 Jan; Vol. 13 (1), pp. e6818. Date of Electronic Publication: 2023 Dec 23.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Changes in key recruitment performance metrics from 2008-2019 in industry-sponsored phase III clinical trials registered at ClinicalTrials.gov.

Authors : Brøgger-Mikkelsen M; Department of Dermato-Venereology, Bispebjerg Hospital, Copenhagen, Denmark.; Studies&Me A/S, Copenhagen, Denmark.

Subjects: Benchmarking* ; Clinical Trials, Phase III as Topic*; Databases, Factual

Source: PloS one [PLoS One] 2022 Jul 26; Vol. 17 (7), pp. e0271819. Date of Electronic Publication: 2022 Jul 26 (Print Publication: 2022).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Impact of oral azithromycin and intermittent preventive treatment with sulfadoxine-pyrimethamine regimen on child mortality in Sierra Leone: trial protocol for a randomised, two-arm, double-blinded, placebo-controlled clinical trial (ICARIA).

Authors : Owusu-Kyei K; Chen H ...

Subjects: Azithromycin*/Azithromycin*/Azithromycin*/administration & dosage ; Azithromycin*/Azithromycin*/Azithromycin*/therapeutic use ; Sulfadoxine*/Sulfadoxine*/Sulfadoxine*/administration & dosage

Source: Trials [Trials] 2024 Sep 27; Vol. 25 (1), pp. 626. Date of Electronic Publication: 2024 Sep 27.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Inclusion of phase III clinical trial costs in health economic evaluations.

Do beta-amyloid-targeted interventions improve cognition, physical functioning, and overt behaviour of Alzheimer's Disease (AD) patients: Protocol for meta-analysis of Phase 3 clinical trials both completed and terminated.

Rapid normalization of vitamin D deficiency in PICU (VITdALIZE-KIDS): study protocol for a phase III, multicenter randomized controlled trial.

Drug-resistant tuberculosis treatments, the case for a phase III platform trial.

A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial.

Adult and pediatric relapsing multiple sclerosis phase II and phase III trial design and their primary end points: A systematic review.

Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis.

Correlation of multiple endpoints in the first-line chemotherapy of advanced gastric cancer: Pooled analysis of individual patient data from Japanese Phase III trials.

Changes in key recruitment performance metrics from 2008-2019 in industry-sponsored phase III clinical trials registered at ClinicalTrials.gov.

Impact of oral azithromycin and intermittent preventive treatment with sulfadoxine-pyrimethamine regimen on child mortality in Sierra Leone: trial protocol for a randomised, two-arm, double-blinded, placebo-controlled clinical trial (ICARIA).

اتصل بنا

اتبع